Udg Healthcare Public Share Discussion Threads

[liarspoker] 28/9/2004 23:12

RNS Number:4103D
United Drug PLC
28 September 2004



UNITED DRUG PLC

New Board Appointments at United Drug plc

United Drug plc is today (Tuesday, 28th September 2004) pleased to announce the
appointment of three new Directors to its Board. Mr. Gary McGann, Chief
Executive of the Jefferson Smurfit Group and Mr. Peter Gray, Chief Executive of
ICON plc join the Board as Non-Executive Directors, and Ms. Annette Flynn, Group
Development Manager of United Drug plc, joins the Board as an Executive
Director.


Mr. Philip Caffrey, an Executive Director since 1976, retires after more than
thirty years with the Company and Mr. Percy Delany, a Non-Executive Director
since 1986, recently reached retirement age and has stepped down from the Board.


Speaking on today's announcements, Mr. Martin Rafferty, Chairman of United Drug
plc said:


"I am delighted that Gary, Peter and Annette are joining the Board of United
Drug. They each bring a combination of experience, skills and perspective that
will benefit our Board in the years ahead as we continue to grow the business
and enhance shareholder value.


"On behalf of the Board I wish to thank Philip and Percy for their contribution
over many years. Over the course of Philip's career with United Drug, he has had
responsibility for three of our four divisions. His contribution has been
substantial. During their tenure of office, both Philip Caffrey and Percy Delany
participated in twenty years of unbroken profit growth at United Drug plc".


For reference: Liam FitzGerald Pauline McAlester
United Drug plc Murray Consultants
Tel: [phone] Tel: [phone]

[liarspoker] 28/9/2004 23:11

RNS Number:3614D
United Drug PLC
27 September 2004

UNITED DRUG plc



27th September 2004



Re: Brochure of Particulars





Pursuant to a Board Meeting on 09 September 2004,a total of 763,213 Ordinary
Shares were allotted in respect of the Customer Share Discount Scheme.



Application has been made to the Irish Stock Exchange and the UK Listing
Authority for these shares to be admitted to the Official List of the Irish
Stock Exchange and the Official List of the UK Listing Authority, and to the
London Stock Exchange for such shares to be admitted to trading. The shares
rank pari-passu in all respects with the existing shares.

[liarspoker] 24/9/2004 12:10

Anyone hold any other ISEQ shares ???

[liarspoker] 23/9/2004 08:39

Morning All.........

[liarspoker] 23/9/2004 00:12

Hope you like the changes to the header. 8-)

[liarspoker] 22/9/2004 16:15

IMHO P/E ratio is fairly cheap for an expanding company with good market share such as this.

The share split has certainly helped marketability too.

[liarspoker] 22/9/2004 12:45

UDG is a pharmaceutical company listed on both the ISEQ and the LSE. It is NOT a growth share as such, however it is an EXCELLENT widows and orphan share. It would do wonders for any long-term portfolio. Granted - the dividend is nothing to write home about but the share performance more than makes up for this.



Acquisitions ( other acquisitions can be found on the UDG website through the link above ):











Excellent UDG Summary :

Another good summary:

The latest presentation:

[liarspoker] 16/9/2004 12:34

Interesting;

RNS Number:0258D
United Drug PLC
16 September 2004

United Drug plc



16 September 2004



Re: Holding in Company







A Letter from Bank of Ireland Asset Management dated 08 September 2004 to The
Irish Stock Exchange, received by The Irish Stock Exchange 16 September 2004.



Notification of Transaction in Shares of Public Limited Companies



I refer to Chapter 2 of Part IV of the Companies Act 1990, which requires
disclosure, by a person who acquires an interest in 5% or more of the issued
Share Capital of a public limited company, to that company of the holding.
Subsequent transitions which change the percentage holding by a whole number
must also be notified.



In this regard I am to notify you of the following holding(s) the percentage of
which has been calculated using an Issued Share Capital of 214,602,367:


No. of Shares Held % of Issued Share Capital after transaction.
14,926,227 6%





Of these shares 14,659,045 units are registered in the name of Bank of Ireland
Nominees Limited, 88,722 units are registered in the name of Nortrust Nominees
and 163,436 units are registered in the name of Citibank Nominees Ltd and 15,024
are registered in the name of Royal Bank of Scotland International Ltd, as
registered owners only, on behalf of a range of clients who are each the
beneficial owner of a portion of the shareholding.







Gary Rahill

Compliance Advisor

Bank of Ireland Asset Management

[liarspoker] 13/9/2004 08:37

New high achieved - 8-)

[liarspoker] 06/9/2004 06:17

If anyone reads this, my advice is to buy UDG for a long-term hold.

Why - well because it has just less then 50% of the drug market in Ireland. UDG is also active in the UK. The share split has helped liquidity which has increased the price nicely.

But best of all - the Irish saving scheme SSIA's will mature in two years. There will be a lot of extra money but allocated to each person there won't be enough for a house deposit so, according to a recent newspaper article, most money will end up in the stock market.

This week should see UDG hit another high. DYOR. 8-)

[liarspoker] 04/8/2004 11:29

Funny to see someone handled just one share so far today !!

[liarspoker] 07/6/2004 10:19

Anyone out there still holding ??

Think this is a great company myself - especially since the split.
These are definitly a long-term holding - not exciting but very rewarding. Decent year upon year growth, lovely indeed.
The strategy: buy and hold

[pharm] 19/1/2004 18:22

Glad I'm not alone.
Two other directors also bought a reasoable qty. in last two weeks.
I think it was 2.3 million euros the boss spent.Don't know if he got them in the market or took them off an institution-I don't think the market could produce 1 million as they are not traded in any great quantity(the spread's large too).

[thebarrelboy] 19/1/2004 11:46

Looking at them - a Director buying £2.3million rather catches the eye does it not?

TBB

[pharm] 16/1/2004 22:04

Big buying by one of the directors today.Anyone out there following this gem apart from Mr Rafferty?

[pharm] 03/12/2003 21:57

I would not sell these at all.Most of the directors have loaded up big time.Also they are in a growing market, which makes a pleasant change.I would also add that they are a prime candidate for a takeover-why it has not come yet I don't know.They are small fish (very) compared with GEHE & Alliance Unichem & will get mopped up sometime, but we could be looking at a few years.
Do not sell these unless you need the money-they are a long term holding to lock away until pay day.
But don't worry if they don't fall to a bidder because profits are heading up and up every year unless something very drastic happens.

[stevecrowe] 27/11/2003 10:47

- Gwendoline

I'd sell if I were you as this share is boring and hardly traded. Good results but not good enough to move north by much a usual.

[gwendoline] 25/11/2003 08:38

Great result from UDG this morning but their price has dropped at start of trading. The market seems to react in some strange ways sometimes! Anyone like to comment on why this is happening?